Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dynavax Technologies Corp (NASDAQ:DVAX)

16.22
Delayed Data
As of May 02
 -0.19 / -1.16%
Today’s Change
15.52
Today|||52-Week Range
32.49
-32.86%
Year-to-Date

Today’s Trading

Previous close16.41
Today’s open16.40
Day’s range15.67 - 16.60
Volume1,393,770
Average volume (3 months)1,107,676
Market cap$631.7M
Dividend yield--
Data as of 4:00pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)+5.80%
Earnings growth (this year)+22.56%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.29%
P/E ratioNM
Price/Sales196.15
Price/Book3.37

Competitors

 Today’s
change
Today’s
% change
CPXXCelator Pharmaceutic...+0.22+1.46%
PDLIPDL BioPharma Inc-0.12-3.18%
SRPTSarepta Therapeutics...+3.73+26.29%
SCLNSciClone Pharmaceuti...+0.53+4.02%
Data as of 4:00pm ET, 05/02/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$4.1M
Annual profit (last year)-$106.8M
Net profit margin-2,636.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts

Partner Offers

Search for Jobs